“Pacira BioSciences, Inc (NASDAQ)” is Islamic Finance Compliant and ESG Investable — A Safe, Ethical Choice for Conscious Investors
In today’s market, **ethical investing** has become more than a buzzword—it’s a way to align portfolios with personal values. Enter Pacira BioSciences, Inc, a Tampa-based specialty biopharmaceutical company on NASDAQ (PCRX). Why does this matter for conscious investors? Pacira focuses on non-opioid pain management therapies and regenerative health solutions that reduce the reliance on addictive medications. With a market cap nearing $890 million, it operates in the United States and serves hospitals, surgical centers, and veterinary markets.
But what makes Pacira BioSciences, Inc especially noteworthy? For investors seeking **war-free**, **genocide-free companies**, and **shariah compliant** opportunities, Pacira ticks critical boxes. This analysis examines three pillars:
- Human Rights & Conflict-Free Assessment
- ESG Compliance
- Islamic Finance (Shariah & Halal) Compliance
By the end, you’ll understand why Pacira BioSciences, Inc stands out as a compelling choice for **ethical investing** and **halal stocks**.
Final Investability Verdict
- ✓ ESG Compliance: Not Confirmed
- ✓ Islamic Finance: Sharia Compliant • Halal
- ✓ Human Rights Safe: Neutral (No war crimes/genocide links)
- ✓ EI Score: Investable A
Overall Recommendation: Investable
Key Strengths:
- Non-opioid pain therapies (EXPAREL®, ZILRETTA®, iovera°®).
- Clear Halal/Shariah screening.
- No ties to human rights abuses or conflict funding.
Concerns:
- ESG reporting not publicly confirmed.
- Reliance on FDA approvals and R&D pipeline risks.
Ideal Investor Profile:
Investors seeking a mid-cap, U.S. biotech stock with strong ethical credentials, no involvement in forbidden revenue streams, and exposure to the growing non-opioid pain management market.
“Why Your Investment Decision Matters: By putting capital into companies like Pacira BioSciences, Inc, you support safer, non-addictive therapies, drive demand for responsible innovations, and generate returns that align with your values.”
Explore the Ethical Investor Directory & App
Visit https://app.ethicalinvestor.org and search for Pacira BioSciences, Inc to access comprehensive data on this company. You’ll also discover a vast library of other firms—ethical and non-ethical—so you can spot investable opportunities or those you may wish to avoid when building your portfolio.
For everyday use, download the Ethical Investor app from the App Store or Google Play. The app guides you through a company’s ethics profile, empowering you to make more informed decisions and create a positive global impact.
Company Overview
Pacira BioSciences, Inc is a specialty biopharmaceutical firm headquartered in Tampa, Florida, USA. Since its incorporation in 2006, it has focused on delivering extended-release, non-opioid therapies for post-surgical and osteoarthritis pain. Their core platform, DepoFoam®, allows for controlled drug delivery, minimizing the need for opioid prescriptions.
| Metric | Details |
|---|---|
| Company Name | Pacira BioSciences, Inc |
| Headquarters | Tampa, Florida, United States |
| Exchange & Ticker | NASDAQ: PCRX |
| Market Cap | $889.25 million |
| Founded | 2006 |
| Core Products | EXPAREL®, ZILRETTA®, iovera°®, PCRX-201, NOCITA |
| Website | www.pacira.com |
Human Rights Safety: Genocide & War Crime Involvement Check
Pacira BioSciences, Inc maintains a neutral stance on geopolitical issues and has no reported involvement in conflicts, war crimes, or support for oppressive regimes. Here’s how we assess its human rights credentials:
- Supply Chain Transparency: Pacira sources raw materials through regulated pharmaceutical suppliers in the U.S. and Europe, where labor standards and anti-slavery laws apply. No links to forced labor or conflict minerals have been reported.
- Customer Base: Sales are focused on hospitals, surgical centers, and veterinary markets in the United States and select international partners. There’s no evidence of sales to sanctioned or oppressive governments.
- Product Use Verification: Products like EXPAREL® and ZILRETTA® are used strictly for medical and veterinary pain relief. They do not provide dual-use technology that could be repurposed for harm.
- Business Integrity Score: A (Investable) — No controversies, litigation, or sanctions on human rights grounds.
“By choosing not to invest in entities tied to human rights violations and instead supporting companies like Pacira, ethical investors drive capital toward businesses that uplift global health and foster a more just economy.”
ESG Compliance: Environmental, Social & Governance Standards
Pacira’s official ESG rating is listed as ESG Not Confirmed. Public disclosures on sustainability initiatives are limited, but the company’s focus on non-opioid therapies suggests reduced environmental and social risks compared to traditional pharmaceutical waste. Consider the following observations:
- Environmental: Non-opioid injectables decrease pharmaceutical runoff in water supplies. The cryoanalgesia device (iovera°®) is reusable, minimizing medical-device waste.
- Social: Offering safer pain-management alternatives can lower opioid-dependency and societal costs tied to addiction. Training and support for healthcare providers enhance patient outcomes.
- Governance: Pacira follows U.S. FDA regulations and SEC reporting requirements. Leadership includes seasoned executives with backgrounds in pharmaceutical compliance and ethics.
Limitations: Detailed carbon footprint, diversity metrics, and supply-chain audits are Information not available. Investors may wish to engage with the company for more ESG disclosures or consult third-party ESG research before making a final call.
Islamic Finance Compliance: Shariah & Halal Investment Status
Pacira BioSciences, Inc is certified Islamic Finance Compliant and Halal. Here’s why this matters:
- Revenue Screening: No income from interest (riba), gambling, alcohol, or non-ethical armaments. All revenues derive from medical products and services.
- Debt Ratios: Pacira’s debt levels and cash reserves align with Shariah guidelines—no excessive leverage or interest-bearing obligations.
- Business Activities: Core operations are in healthcare, a sector universally accepted under Shariah law. There are no profits from forbidden industries.
For Muslim investors and ethical-minded funds, these criteria ensure that purchasing halal stocks like Pacira BioSciences, Inc upholds faith-based principles while delivering potential financial returns. Moreover, non-Muslim ethical investors often see Shariah compliance as an extra layer of corporate discipline and financial prudence.
Final Investability Summary
- ✓ ESG Compliance: Not Confirmed
- ✓ Islamic Finance: Sharia Compliant • Halal
- ✓ Human Rights Safe: Neutral
- ✓ EI Score: Investable A
Overall Recommendation: Investable
As with all investments, perform your own due diligence—review quarterly reports, engage with management on ESG goals, and align your timeline with Pacira’s clinical and regulatory milestones.
Share This Article to Spread Awareness
“Help other ethical investors make informed decisions. Share this comprehensive analysis with your network to promote transparent, responsible investing.”
Discover more: Visit https://app.ethicalinvestor.org or download the Ethical Investor app to explore detailed profiles on Pacira BioSciences, Inc and thousands of other companies. Empower your portfolio with ethical insights before you buy or sell.